We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSBD:NYSEPalmer Square Capital BDC Inc. Analysis

Data as of 2026-06-14 - not real-time

$10.77

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Palmer Square Capital BDC trades around $10.77, just above its 20‑day SMA (≈$10.75) and 50‑day SMA (≈$10.70) but well below the 200‑day SMA (≈$11.67), signaling a short‑term neutral stance within a longer‑term downtrend. The RSI sits near 51 and the MACD has turned bearish, while volume has been slipping, suggesting limited upside momentum. On the fundamentals side, the forward P/E of roughly 7.6 is well under the industry average of 16.8, indicating an undervalued price, yet the dividend yield of ~14% is backed by a payout ratio near 400%, raising serious sustainability concerns. Recent board approval to increase and extend the share‑repurchase program signals management confidence, but the high dividend payout and a max drawdown of about 34% underscore the need for caution.
Overall, PSBD offers an attractive valuation and a low beta (≈0.54) that tempers market risk, but the combination of a bearish technical picture, decreasing liquidity, and an unsustainable dividend suggests a watchful‑wait approach rather than aggressive buying.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above short‑term support (≈$10.5)
  • Bearish MACD and decreasing volume
  • High, likely unsustainable dividend yield

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued forward P/E (~7.6) versus industry
  • Share‑repurchase program indicating management confidence
  • Continued dividend sustainability concerns

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low beta and moderate volatility reduce market risk
  • Potential earnings upside reflected in positive forward EPS
  • Value‑oriented pricing with room for price appreciation if dividend policy stabilizes

Key Metrics & Analysis

Financial Health

P/E Ratio7.7
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI50.9
Support$10.50
Resistance$11.06
MA 20$10.75
MA 50$10.70
MA 200$11.67
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Target Price$11.00
Upside/Downside2.14%
GradeUndervalued
TypeValue
Dividend Yield13.93%

Risk Assessment

Beta0.54
Volatility20.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.